Oncogenic role of dysregulated leptin signaling in the pathogenesis of ovarian cancer

被引:0
|
作者
Iman W. Achkar
Ajaz A. Bhat
Maria Zafar
Madiha Abbas
Omar S. Khan
Shilpa Kuttikrishnan
Kirti S. Prabhu
Shahab Uddin
机构
[1] Hamad Medical Corporation,Translational Research Institute, Academic Health System
[2] Sidra Medicine,Department of Biochemistry
[3] Research Branch,undefined
[4] Aligarh Muslim University,undefined
[5] University of Illinois at Chicago,undefined
关键词
Leptin; Ob-R; PI3K/AKT pathway; Ovarian Cancer;
D O I
10.1186/s41231-018-0031-2
中图分类号
学科分类号
摘要
Leptin, a pleiotropic hormone is produced by adipose tissues and plays a critical role in various biological functions. Leptin mediates its function through interaction with specific receptors. The leptin-receptor interaction modulates activation of a number of signaling pathways, such as JAK-STAT, PI3-Kinase-AKT and MAP kinases. Recently, deregulated leptin-mediated signaling has been shown in many cancers including ovarian cancer. A number of studies have shown a link between obesity and carcinogenesis of different cancers via leptin deregulated signaling pathways. In this review, we highlighted the role of deregulated leptin receptor-mediated signaling in the etiology of ovarian cancer.
引用
收藏
相关论文
共 50 条
  • [31] Role of Leptin Signaling in the Pathogenesis of Angiotensin II-Mediated Atrial Fibrosis and Fibrillation
    Fukui, Akira
    Takahashi, Naohiko
    Nakada, Chisato
    Masaki, Takayuki
    Kume, Osamu
    Shinohara, Tetsuji
    Teshima, Yasushi
    Hara, Masahide
    Saikawa, Tetsunori
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02): : 402 - 409
  • [32] Oncogenic role of eIF-5A2 in the development of ovarian cancer
    Guan, XY
    Fung, JMW
    Ma, NF
    Lau, SH
    Tai, LS
    Xie, D
    Zhang, Y
    Hu, L
    Wu, QL
    Fang, Y
    Sham, JST
    CANCER RESEARCH, 2004, 64 (12) : 4197 - 4200
  • [33] Role of Notch signaling pathway in gastric cancer pathogenesis
    Brzozowa, Marlena
    Mielanczyk, Lukasz
    Michalski, Marek
    Malinowski, Lukasz
    Kowalczyk-Ziomek, Grazyna
    Helewski, Krzysztof
    Harabin-Slowinska, Marzena
    Wojnicz, Romuald
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (01): : 1 - 5
  • [34] Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics
    Riobo-Del Galdo, Natalia A.
    Lara Montero, Angela
    Wertheimer, Eva V.
    CELLS, 2019, 8 (04)
  • [35] Role of adenosine signaling in the pathogenesis of head and neck cancer
    Khayami, Reza
    Toroghian, Younes
    Bahreyni, Amirhossein
    Bahrami, Afsane
    Khazaei, Majid
    Ferns, Gordon A.
    Ebrahimi, Safieh
    Soleimani, Anvar
    Fiuji, Hamid
    Avan, Amir
    Hassanian, Seyed Mahdi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (10) : 7905 - 7912
  • [36] Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer
    Soleimani, Atena
    Rahmani, Farzad
    Ferns, Gordon A.
    Ryzhikov, Mikhail
    Avan, Amir
    Hassanian, Seyed Mahdi
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (39) : 4605 - 4610
  • [37] Dysregulated RET signaling in thyroid cancer
    Castellone, Maria Domenica
    Santoro, Massimo
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (02) : 363 - +
  • [38] Exploring Dysregulated Signaling Pathways in Cancer
    Nisar, Sabah
    Hashem, Sheema
    Macha, Muzafar A.
    Yadav, Santosh K.
    Muralitharan, Sankavi
    Azeez, Lubna
    Sageena, Geetanjali
    Al-Naemi, Hamda
    Haris, Mohammad
    Bhat, Ajaz A.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (04) : 429 - 445
  • [39] Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells
    Chin, Yu-Tang
    Wang, Le-Ming
    Hsieh, Meng-Ti
    Shih, Ya-Jung
    Nana, Andre Wendindonde
    Changou, Chun A.
    Yang, Yu-Chen S. H.
    Chiu, Hsien-Chung
    Fu, Earl
    Davis, Paul J.
    Tang, Heng-Yuan
    Lin, Hung-Yun
    JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24
  • [40] Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells
    Yu-Tang Chin
    Le-Ming Wang
    Meng-Ti Hsieh
    Ya-Jung Shih
    André Wendindondé Nana
    Chun A. Changou
    Yu-Chen S. H. Yang
    Hsien-Chung Chiu
    Earl Fu
    Paul J. Davis
    Heng-Yuan Tang
    Hung-Yun Lin
    Journal of Biomedical Science, 24